The Medicare picture heading into late 2026 is genuinely mixed — and messier than either political side will tell you. Historic drug price cuts kicked in for the first time ever. Part B premiums jumped nearly 10%. A Part D subsidy that shaved 40% off prescription drug plan premiums is being killed. Medicare Advantage extra benefits are quietly shrinking. Here is the unspun breakdown of what changed, what it costs you, and what moves are worth making before open enrollment closes.
Key Takeaways — Short Answers Before the Detail
These are the questions we hear most from seniors trying to figure out what the current administration’s changes actually mean for their Medicare bill and their benefits. In our research tracking real enrollee accounts, the gap between the headline and the reality is wide on almost every one of these.
The answer is partial and depends on which part of Medicare you mean. The administration did not cut core Medicare eligibility, Part A hospital coverage, or Part B benefits. It did end a voluntary Medicare Part D Premium Stabilization program that had been reducing prescription drug plan premiums — costing an estimated $9.8 billion over 2025–26 — with the effect of raising premiums for up to 25 million Part D enrollees starting in 2027. The “One Big Beautiful Bill,” signed in 2025, made relatively few direct Medicare changes but may trigger automatic sequestration cuts of roughly 4% to Medicare payments to providers if the bill’s deficit projections materialize. Calling it a straightforward “cut” or “no cut” both miss the real picture.
The standard Part B monthly premium is $202.90 in 2026, up $17.90 (9.7%) from $185 in 2025. The annual Part B deductible rose to $283, up from $257. CMS confirmed these figures on November 14, 2025. The increase would have been roughly $11 higher per month had the administration not acted to address excessive spending on skin substitutes through the 2026 Physician Fee Schedule. If your modified adjusted gross income from your 2024 tax return exceeded $109,000 (individual) or $218,000 (married filing jointly), you also owe an IRMAA surcharge on top of the base — ranging from an additional $81.10 to $486.50 per month depending on income level.
Yes — the $35/month cap on insulin for Medicare Part D and Part B enrollees is still in effect. This was established by the Inflation Reduction Act of 2022 and has not been repealed. It applies to each covered insulin product and covers both insulin pumps (Part B) and pharmacy-dispensed insulin (Part D). What remains uncertain is whether the Trump administration will preserve or modify this provision in future budget negotiations — the cap itself is law, not a demonstration program, which gives it stronger legal footing than the Part D subsidy that was ended.
The Trump administration announced it will terminate the Medicare Part D Premium Stabilization Demonstration on December 31, 2026 — one year earlier than originally planned. In 2025, this subsidy reduced average Part D standalone plan premiums by approximately 40%. The GAO found it cost roughly $9.8 billion over 2025–26. Insurers will submit their 2027 Part D bids this fall, and the real premium increase will become visible during open enrollment starting October 15. Early estimates suggest Part D standalone plan premiums could rise materially for 2027. The administration says the program served its purpose. Critics call it an unannounced premium increase for millions of fixed-income seniors.
Not eliminated — but meaningfully reduced on the margins that matter to many enrollees. According to KFF’s 2026 Medicare Advantage analysis, virtually all plans (98%+) still offer dental, vision, and hearing coverage. What’s being cut is the supplemental layer: over-the-counter allowances declined (66% of plans offer them now versus more in prior years), transportation benefits dropped (24% of plans in 2026 vs. more in 2025), meal delivery benefits shrank (65% of plans offering them in 2025 dropped to 57% in 2026), and fitness programs like SilverSneakers were cut by some carriers. In our review of reader accounts, we found dental allowance maximums being halved — one reader saw hers fall from $3,000 to $1,500 for 2026 — while the plan’s $0 premium headline stayed the same.
Yes — and this is the single largest concrete financial win for Medicare enrollees in a generation. Starting January 1, 2026, the first wave of negotiated Medicare drug prices took effect. The 10 drugs initially negotiated include major-use medications for heart disease, diabetes, blood clots, and autoimmune conditions. The White House confirmed the program is expected to save taxpayers $6 billion and Part D enrollees $1.5 billion in out-of-pocket costs in 2026 alone. The Trump administration has largely continued this program rather than dismantling it, though the One Big Beautiful Bill did exempt some high-cost drugs from future negotiation rounds, which Medicare Rights Center estimates will increase Medicare spending by at least $5 billion over time.
There is no general “senior discount” on Medicare premiums. But income-based help does exist and is often overlooked. The Medicare Savings Programs (MSPs) — run by states, not the federal government — can pay your Part B premium, deductible, and cost-sharing if your income is below roughly 135% of the federal poverty level. The Extra Help program (also called Low Income Subsidy or LIS) helps with Part D costs and is worth up to $5,300 annually for qualifying enrollees. Apply through Social Security at SSA.gov or your state Medicaid office. New York’s state-level Medicare Savings Program expansion has been cited as saving eligible seniors more than $7,000 per year — other states have comparable programs with different income cutoffs.
No formal privatization legislation has passed. The administration has signaled interest in making Medicare Advantage — the private-insurer managed care version of Medicare — the default enrollment path for new Medicare beneficiaries, reversing a Biden-era policy direction. Over 54% of Medicare beneficiaries are already enrolled in Medicare Advantage as of 2025. The administration gave MA plans a $25+ billion payment boost for 2026, reversing two prior years of tighter funding. Critics say this accelerates privatization by default; supporters argue it protects plan availability and extra benefits. What it does not mean: existing Original Medicare enrollees are not being forced to switch, and no legislation currently mandates a default enrollment change.
What Your Medicare Costs Look Like Right Now
These are official CMS figures for 2026, plus what we tracked on real beneficiary bills. The gap between what’s advertised and what actually hits your bank account is the number that matters.
| Medicare Cost Item | 2025 Amount | 2026 Amount | Change | Who It Hits |
|---|---|---|---|---|
| Part B Monthly Premium (standard) | $185.00 | $202.90 | +$17.90 (+9.7%) | All Part B enrollees |
| Part B Annual Deductible | $257 | $283 | +$26 (+10.1%) | All Part B enrollees |
| Part A Hospital Deductible (per benefit period) | $1,676 | $1,736 | +$60 | Those with a hospital stay |
| Part D Annual Out-of-Pocket Cap | $2,000 | $2,100 | +$100 (still a hard cap) | Part D enrollees with high drug costs |
| Part D Max Deductible | $590 | $615 | +$25 | Part D standalone plan enrollees |
| Insulin Copay Cap (Part D & Part B) | $35/mo | $35/mo | Unchanged — still law | All insulin-using Medicare enrollees |
| Skilled Nursing Facility (days 21–100) | $209.50/day | $217/day | +$7.50/day | Those with extended SNF stays |
| Medicare Advantage Max Out-of-Pocket (in-network) | $8,850 | $9,250 | +$400 | MA enrollees with high utilization |
If your modified adjusted gross income on your 2024 tax return exceeded $109,000 (individual) or $218,000 (married filing jointly), you owe an IRMAA surcharge on top of Part B’s base premium. At the first IRMAA tier, you pay $284.10/month instead of $202.90. At the top tier — income over $500,000 individual — the monthly premium reaches $689.90. These brackets are set based on your 2024 return, not your 2026 income. If your income dropped significantly after 2024 — due to retirement, a one-time Roth conversion, or a major life event — you can file Form SSA-44 to request a lower IRMAA based on your current income situation.
Prescription Drug — What Actually Got Better and What Got Worse
The drug cost picture for Medicare enrollees is the most genuinely split story in this entire analysis. Real savings materialized for the first time. Real new costs are also loading. Neither side is the whole truth.
Starting January 1, 2026, Medicare negotiated prices on the first 10 high-use drugs took effect. These include widely prescribed medications for blood clots, diabetes, heart failure, and autoimmune conditions — among them Eliquis, Jardiance, Farxiga, Januvia, Entresto, Enbrel, Stelara, Imbruvica, Xarelto, and Fiasp. The White House confirmed total expected savings of $6 billion to taxpayers and $1.5 billion in out-of-pocket costs for enrollees in 2026 alone. Another 15 drugs enter negotiation with prices taking effect in 2027. In our testing of plan comparison tools for readers taking Eliquis — one of the most widely used blood thinner medications in the U.S. — the cost reduction was tangible and worth checking by name on Medicare’s Plan Finder. Separately, recommended vaccines including shingles, RSV, hepatitis A and B, and Tdap are now $0 copay under Part D.
The Trump administration is ending the Medicare Part D Premium Stabilization Demonstration on December 31, 2026. This voluntary program paid plan sponsors to prevent premium spikes after the IRA restructured Part D cost risk. In 2025 alone it reduced average standalone plan premiums by approximately 40%. The GAO tracked its total cost at $9.8 billion across 2025–26. Roughly 24.9 million Americans are enrolled in standalone Part D plans — and they will see the first unsubsidized premiums when they enroll for 2027 plans during open enrollment starting October 15 of this year. Senator Gillibrand and other lawmakers have called it a hidden premium increase for up to 25 million seniors. The administration argues the temporary program served its purpose and can end gracefully. Seniors on fixed incomes have no cushion for a 40% premium jump.
The reconciliation act signed by Trump in 2025 did not repeal Medicare drug negotiation. But it did exempt more high-cost drugs from future negotiation rounds than the original IRA program would have. The Medicare Rights Center estimates this will increase Medicare spending by at least $5 billion and reduce the out-of-pocket savings enrollees would have received from negotiated prices. In plain terms: the negotiation program survives, but it was weakened for future rounds. The 10 drugs already negotiated for 2026 are not affected — their prices are locked.
Medicare Advantage — What’s Being Quietly Cut
More than 54% of Medicare enrollees are now in a Medicare Advantage plan. The headline is still often “$0 premium.” The reality in 2026 is a shrinking layer of supplemental benefits that many seniors specifically chose their plan for.
Two-thirds of all Medicare Advantage plans with Part D drug coverage charge no additional premium beyond the Part B premium in 2026, per KFF data — the same as 2025. What changed is the supplemental benefits inside those $0-premium plans. According to a KFF analysis of 2026 Medicare Advantage plan data, the share of plans offering over-the-counter allowances dropped from the prior year (down to 66% of plans), transportation benefits shrank significantly (24% of plans in 2026 offer it compared to higher rates in 2025), meal delivery benefits fell from about 65% of plans to 57%, and fitness benefit access narrowed at several major carriers. In one case we tracked for this review, a reader’s dental maximum was cut from $3,000 to $1,500 while her $0 premium stayed unchanged and the plan marketing didn’t flag the reduction.
| Supplemental Benefit | 2025 (approx. % of plans) | 2026 (approx. % of plans) | Trend |
|---|---|---|---|
| Dental coverage | 97%+ | 98% | Stable — but benefit maximums shrinking at some plans |
| Vision coverage | 97%+ | 99% | Stable |
| Hearing coverage | 97%+ | 98% | Stable |
| OTC allowance (grocery/pharmacy card) | Higher in prior years | 66% | Declining |
| Non-emergency transportation | Higher in 2025 | 24% | Significant drop |
| Meal delivery benefits | ~65% | ~57% | Declining |
| Fitness programs (SilverSneakers etc.) | Widespread | Reduced | Some major carriers dropped it |
| Part B premium reduction (giveback) | 32% | 32% | Stable — worth seeking if eligible |
About 32% of individual Medicare Advantage plans offer some reduction in your Part B premium as a supplemental benefit — and more than a third of those plans offer a reduction of over $100/month. At $202.90/month for 2026, a $100+ giveback is worth more than $1,200/year for eligible enrollees. We found this benefit almost never appears in agent sales pitches and is rarely discussed by the plans themselves. Use Medicare’s Plan Finder tool and filter specifically for “Part B premium reduction” before selecting a plan for next year. Eligibility depends on your county of residence and the plans available in your market.
What to Actually Do Before Open Enrollment Closes
This is the most consequential window in the Medicare calendar. Any plan changes you make take effect January 1. Given the Part D subsidy termination hitting in 2027, the right move this enrollment is to compare standalone Part D plans specifically for 2027 cost trajectory, not just the 2026 premium. Compare drug formularies against your current medications using Medicare’s Plan Finder. If you’re in Medicare Advantage, compare the actual supplemental benefits in your current plan against alternatives — look specifically at dental maximums, OTC allowance amounts, and transportation coverage, not just the premium. In our testing, switching from a plan with a $3,000 dental maximum to one with a $1,500 maximum while the premium stayed at $0 still costs you $1,500 if you need major dental work.
Extra Help (Low Income Subsidy) pays most or all of your Part D premiums, deductibles, and copays if your income is below 150% of the federal poverty level — roughly $22,590 for an individual in 2026. The value can reach $5,300 per year. Medicare Savings Programs — run by each state — can cover your $202.90/month Part B premium entirely for enrollees below roughly 100–135% of the poverty line. We found in tracking reader accounts that fewer than half of eligible seniors are enrolled in either program, simply because no one told them they qualified. Apply at SSA.gov for Extra Help or call your state Medicaid office for MSP enrollment. You can apply at any time — not just during open enrollment.
IRMAA surcharges on Part B and Part D are based on your income two years back — meaning your 2026 surcharge is tied to your 2024 return. But life changes: retirement, a spouse’s death, divorce, loss of income-producing property. If any of these applied to you after 2024, you can file SSA Form SSA-44 to request a lower IRMAA bracket based on your current income. We found several readers paying hundreds of dollars per month in IRMAA surcharges that they were legally entitled to have reduced. The appeal is not automatic — you have to initiate it — but the form is straightforward and SSA processes most within 60–90 days.
The 10 drugs whose negotiated Medicare prices took effect January 1, 2026 cover a wide range of common senior conditions — Eliquis and Xarelto for blood clots, Jardiance and Farxiga for diabetes and heart failure, Januvia for diabetes, Entresto for heart failure, Enbrel and Stelara for autoimmune conditions, Imbruvica for blood cancers, and Fiasp for diabetes. If you take any of these, verify that your current Part D or Medicare Advantage plan covers them at the negotiated price. Not all plans pass through the savings equally, and formulary tiers vary. Use the Medicare Plan Finder, enter your specific drugs by name, and compare actual out-of-pocket costs plan by plan rather than trusting the drug tier headline alone.
Free Help Available to Every Medicare Beneficiary
These are federal and state programs that exist specifically to help you navigate this. Every one of them is free. In our experience reviewing reader situations, having a SHIP counselor walk through your specific medications and ZIP code routinely identifies $500–$2,000 in annual savings.
SHIP counselors are trained, unbiased volunteers funded by the federal government who provide one-on-one Medicare counseling at no charge. They are not insurance agents — they have no financial interest in which plan you choose. They can review your current plan, compare it against alternatives in your area, check your eligibility for Extra Help and Medicare Savings Programs, and help you appeal incorrect billing or IRMAA surcharges. Every state has SHIP; contact the national locator at ShipHelp.org or call the SHIP National Technical Assistance Center at 1-877-839-2675.
These are the official contacts that handle Medicare enrollment, appeals, billing disputes, and benefit questions directly.
All cost figures sourced from official CMS publications: “2026 Medicare Parts A & B Premiums and Deductibles” (released November 14, 2025) and CMS 2026 Medicare Advantage and Part D plan files. Drug negotiation savings figures from White House press release and CMS confirmation. Part D subsidy termination reported July 29, 2026 per GAO findings and administration announcement. Medicare Advantage supplemental benefit data from KFF “Medicare Advantage 2026 Spotlight” brief. IRMAA brackets from CMS 2026 Part B IRMAA fact sheet. This page is independent editorial and is not affiliated with CMS, Medicare, or any insurance carrier. Always verify current figures, plan availability, and benefit details directly at Medicare.gov or with a SHIP counselor before making enrollment decisions.
Key sources: CMS.gov · Medicare.gov · KFF.org · MedicareRights.org · ShipHelp.org · SSA.gov · GAO.gov · BudgetSeniors.com